Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
The purpose of this study is to assess gastroprotective agent compliance in patients at risk suffering from a gastrointestinal bleeding ulcer or a symptomatic ulcer with NSAID.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| 1 |
Not provided
| Measure | Description | Time Frame |
|---|---|---|
| Gastroprotective agent compliance | At the end of 1 month |
| Measure | Description | Time Frame |
|---|---|---|
| Clinical characteristics of those ulcers with NSAID | At the end of 1 month |
Not provided
Inclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Hospital sample
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Jean-Francois Bretagne | Service gastro-enterologie et hepatologieCHRU Pontchaillou35033 RENNES cedex France | Study Chair |
| Gerard Thiefin | Service Hepato-Gastroenterologie CHU Reims51092 REIMS cedex France | Study Chair |
| Genevieve BONNELYE | KantarHealth - France138, avenue Marx Dormoy92120 Montrouge cedex | Principal Investigator |
Not provided
Not provided
| ID | Term |
|---|---|
| D006471 | Gastrointestinal Hemorrhage |
| D014456 | Ulcer |
| D010349 | Patient Compliance |
| ID | Term |
|---|---|
| D005767 | Gastrointestinal Diseases |
| D004066 | Digestive System Diseases |
| D006470 | Hemorrhage |
| D010335 | Pathologic Processes |
Not provided
Not provided
Not provided
Not provided
Not provided
| D013568 |
| Pathological Conditions, Signs and Symptoms |
| D010342 | Patient Acceptance of Health Care |
| D000074822 | Treatment Adherence and Compliance |
| D015438 | Health Behavior |
| D001519 | Behavior |